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Introduction: Haemophilic arthropathy following recurrent joint bleedings is one of the major disease-related
complications in people with haemophilia (PWH), leading to mostly chronic joint pain. Since many antinociceptive
principles interfere with the clotting system, PWH are restricted in treatment options, thereby defining a medical
need for novel therapeutic principles. However, we lack the availability of an animal model for joint pain in
haemophilic arthropathy for testing these.
Methods: In this study, we aimed to validate the rat model of repeated autologous intraarticular blood injections
specifically for pain-related behavior. During an observation period of 50 days, groups of animals were injected
weekly into one knee joint with either whole blood or cellular/plasma components.
Results: Injections induced primary hyperalgesia starting after the third injection, accompanied by mild functional
gait changes and joint swelling. Secondary hyperalgesia and quantitative gait disturbances were not observed. This
phenotype was most prominent in whole blood injected animals, with effect sizes of cells and plasma being
additive. In order to differentiate haemophilia-related arthropathy from traumatic joint bleeding, another group was
injected with whole blood only once, which did not cause any alterations.
Conclusions: Repeated autologous intraarticular injections of blood showed a time course, inflammatory response
and reduction in pain thresholds similar to the signs and symptoms observed in PWH. Therefore, this model may
be utilised in the future for testing novel antinociceptive principles in haemophilia-associated joint pain.Introduction
Haemophilia is the most common genetic clotting disorder
and is subdivided into haemophilia A (deficiency in bio-
logically active clotting factor VIII) with a prevalence of
1:10,000, and haemophilia B (deficiency in biologically ac-
tive clotting factor IX) with a prevalence of 1:50,000 [1].
Since substitution therapy is broadly available, the rate
of life-threatening bleedings has dramatically decreased.
However, not all bleedings can be avoided, and of these,
85% occur in joints [2], leading to so-called haemophilic ar-
thropathy in the long term. The latter is characterized by* Correspondence: mkboettger@gmx.de
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reproduction in any medium, provided the orcartilage destruction and synovitis which translate into the
clinical sign loss of function and symptom joint pain [3,4].
Joint pain in people with haemophilia (PWH) reflects a
major clinical problem which starts in early childhood [5].
More than half of the people affected complain about daily
joint pain episodes [6], and experimental data have shown
a significant reduction of pain thresholds at the joints of
PWH [4]. Treatment options for joint pain in PWH are
limited, since substances interfering with blood clotting,
for example, cyclooxygenase inhibitors, are not unequivo-
cally recommended. Therefore, new therapeutic ap-
proaches are warranted. Preclinical testing of such novel
antinociceptive principles, however, lacks haemophilia ani-
mal models which are specifically validated for the assess-
ment of pain-related behaviour.
We aimed to test whether the previously described
model of blood-induced arthropathy in rats [7] may reflect
a suitable model for haemophilic joint pain. In particular,l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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questions: 1) do animals which are repeatedly injected
with blood, display a pain phenotype and can this model
thus be validated and used for pain research in haemo-
philia? 2) what is the relative importance of blood cells
and plasma as compared to whole blood on pain-related
behaviour and inflammation? and 3) does a single injec-
tion of blood, as, for example, observed in joint trauma,
cause sustained alterations in inflammation and a pain
phenotype, or how does this differentiate from repeated
injections?
In order to answer these questions, we simulated joint
bleeding by repeated (or single, respectively) homologous
intraarticular injections. These were performed either
using saline or whole blood, and for the repeated injec-
tions isolated plasma or isolated blood cells were also
used. In the course of up to 50 days after the first injec-
tion, pain-related behaviour and inflammatory changes
were assessed in these animals, including measures of pri-
mary and secondary hyperalgesia, functional parameters,




For the experiments, 63 female Lewis rats (six to eight
weeks old, weight 160 to 180 g upon arrival, supplied by
Charles River Laboratories, Sulzfeld, Germany) were used.
Animals were housed in a 12:12 hour light:dark cycle and
received standard rodent chow and water ad libitum. Be-
havioural tests were performed between 8 a.m. and 11 a.
m. in a constantly lit and climatized room. All experi-
ments were approved by the Thuringian state authorities
(registration number 02-027/10) and complied with EC
regulations (86/609/EEC) for the care and use of labora-
tory animals. Furthermore, the study complies with the
ethical guidelines for the assessment of pain in laboratory
animals published by the International Association for the
Study of Pain [8]. An Extended Methods Form (EMF) for
uniform reporting standards as recommended by Rice and
coworkers [9] can be found in Additional file 1.
Treatment protocol and groups
Autologous intraarticular injections were performed repeat-
edly on days 0, 7, 14, 21, 28, 35, 42 and 49. On each injec-
tion day, rats were briefly anesthetized using 2% isoflurane
(Isofluran Delta Select, Dreieich, Germany). Blood was
drawn from the coccygeal vein after slight warming of the
tail using a 100 W infrared lamp (Sanitas SIL5, Dinslage
GmbH, Uttenweiler, Germany) using a 26 G cannula (vol-
ume: 0.3 ml). The blood or the respective blood component
was then immediately injected in the left knee joint of the
same animal (autologous blood injection) using a 27 G can-
nula and an injection volume of 0.1 ml (see below).In order to differentiate between effects of whole blood
(WB), the cellular compartment (white and red blood
cells) and the blood plasma, the following groups were in-
vestigated: 1) saline injections (n = 9); 2) whole blood in-
jections (n = 9); 3) blood plasma injections (n = 9); 4)
injection of cellular blood components (n = 9); and 5) in-
jection of saline containing lithium-heparin (n = 5). For
group 2, the blood was directly re-injected. For groups 3
and 4, the obtained blood was transferred into a tube cov-
ered with lithium and heparin (Microvette 300 LH,
Sarstedt, Nürmbrecht, Germany). The samples were then
centrifuged at 2,000 × g at room temperature for five mi-
nutes (Heraeus Biofuge 13, Heraeus, Osterode, Germany).
For injection of plasma (group 3, cell-free solution), a
haematocrit of 40% was assumed, such that 0.04 ml of
0.9% NaCl solution was added to 0.06 ml of plasma. For
injection of blood cells without plasma (group 4), the
plasma supernatant was removed, and the withdrawn vol-
ume was replaced by saline. Of this suspension, again 0.1
ml was injected into one knee joint.
In order to differentiate the effects on pain-related be-
haviour between (single) traumatic joint bleeding and
haemophilic arthropathy, two additional groups were ex-
amined in which blood (n = 10) or saline (n = 8) was
injected only once (that is, one week after the second
baseline testing, groups 6 and 7, respectively) on day 0. In
an additional three animals, whole blood was injected
weekly according to the aforementioned protocol, and sin-
gle animals were sacrificed after three, five or eight injec-
tions in order to obtain histology (see below) at these time
points. One naïve animal was further sacrificed for base-
line knee histology (without any injection).
Pain-related behaviour
Tests for pain-related behaviour were performed twice be-
fore the first blood injection in order to acclimatize the ani-
mals to the experimental setting and in order to obtain
baseline values (for the latter, the values obtained from the
second testing were utilized). For all groups, the behavioural
tests described below were performed on days 1, 8, 15, 22,
29, 36, 43 and 50 (that is, always one day after blood or
blood compartment injection, when performed repeatedly).
Stimulus-evoked parameters
Primary mechanical hyperalgesia at the site of the inflamed
knee was assessed using a pressure application measure-
ment device (PAM, Ugo Basile, Comerio, Italy) as described
previously [10]. In brief, constantly increasing pressure
(50 g/second) was applied to the lateral side of the knee
joint at the level of the joint space until the animals
attempted to escape or vocalized. The weight force to elicit
this response was read out in grams. For each animal and
testing day, this test was performed once, since repeated
testing might further sensitize the nociceptive apparatus.
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ways: mechanical thresholds as described above were
obtained from the contralateral knee joint using the PAM
device. In addition, secondary mechanical hyperalgesia
at the paw was assessed using a dynamic plantar
aesthesiometer (Ugo Basile) which applied increasing
pressure (linear increase in weight force, 2.5 g/second). The
weight force eliciting leg withdrawal reflects the respective
mechanical threshold. Three consecutive stimuli were
applied and the mean force was calculated.
Thermal secondary hyperalgesia at the hind paws was
assessed using an algesimeter (Ugo Basile) as described
previously [11]. After accommodation of the animals to
the testing device, three consecutive standardized heat
stimuli were applied to the hind paws with at least two mi-
nute intervals between stimuli. Mean latencies were calcu-
lated and used as a measure of withdrawal threshold to
heat. Stimuli were applied for a maximum of 20 seconds.
Functional parameters
Pain-related guarding behaviour of the inflamed hind paw
was assessed by quantification of weight bearing towards
the non-inflamed hindlimb using an incapacitance tester
(Linton Intrumentation, Norfolk, UK). Here, animals were
placed in a plastic cage with both hind-paws resting on
scales. After accommodation to the device when the ani-
mal was sitting calmly, the weight force resting on the two
scales was obtained and averaged over three seconds and
values from three consecutive measurements were aver-
aged for every testing day. From these values, the relative
weight (in %) resting on the inflamed hindlimb was calcu-
lated (weight on inflamed hindlimb × 100%/(weight on
the inflamed + the non-inflamed hindlimb)) as described
previously [12,13].
In addition, a semiquantitative guarding score was
assessed as described previously [14]: 0: no guarding, 1:
guarding of the hindlimb after a defined brief noxious
compression of the knee, 2: visible limping during walk-
ing without previous pain stimulus, 3: no use of the
hindlimb with the arthritic knee, 4: no movement at all
(general morbidity).
For quantitative gait analysis, paw print analyses were
used as described previously [15]. Here, animals were gen-
tly placed in a piece of cloth and hind paws were stained
with liquid dye. Then the rats were placed in the opening
of a tunnel, which they entered following their instinct to
go to the dark, leaving their paw prints on blotting paper.
From these paw prints, the following parameters were
obtained: the distance between a print from the left paw
and a consecutive print from the right paw or vice versa
(left-right- or right-left-distance, respectively) and the
angle between consecutive paw prints (defined by a line
through the incision of the paw print and the third phal-
anx). For each animal and testing day, at least five artifact-free gait cycles (four consecutive prints) were analyzed
and means of these values were used for further analysis.
Histology and grading of arthritis
Swelling was assessed by measuring the medio-lateral dia-
meter of each knee joint using a vernier caliper (Mitutoyo,
Neuss, Germany). For each animal and testing day, the
relative swelling was calculated by subtracting the diameter
of the non-injected from the injected knee, thus controlling
for anatomical knee joint differences between animals.
Histology of the knee joints was assessed on day 50
(except for those animals that were sacrificed after three or
five injections, see above). Rats were deeply anesthetized
with 120 mg/kg sodium thiopentone i.p. (Trapanal, Byk
Gulden, Konstanz, Germany) and sacrificed. The knee joints
were removed, skinned, post-fixed in formalin, decalcified in
7% AlCl3 (in 2.1% HCl and 6% formic acid) for 48 hours,
embedded in paraffin, cut into 5 μm thick frontal sections,
and stained with haematoxylin-eosin. Two independent
observers unaware of the treatment scored the sections
(0: no, 1: mild, 2: moderate, 3: severe alterations). The
amount of fibrin exudation, the relative number and density
of granulocytes in synovial membrane and joint space
allowed grading of the acute inflammatory reaction, and the
relative number and density of infiltrating mononuclear
leukocytes in the synovial membrane, the degree of synovial
hyperplasia, the extent of infiltration and fibrosis in the
peri-articular structures allowed grading of chronic inflam-
mation. Cartilage and bone destruction (taken together as
‘joint destruction’) were also scored (0: no erosion, 1: erosion
of <10%, 2: of 10% to 25%, 3: of 25% to 50%, and 4: of >50%
of cartilage and bone in cross sections) [14,16]. Histological
pictures for Figures 1 and 2 were obtained using Mirax Scan
150 (Zeiss, Jena, Germany).
Statistical analyses
For statistical analyses, SPSS for Windows (version 17.0)
was used. First, all data were tested for normal distribu-
tion applying Kolmogoroff-Smirnoff-tests.
In order to test significant group differences over time in
those animals receiving repeated injections, repeated
measures analysis of variance (ANOVAs) were performed
with the between subjects factor ‘GROUP’ consisting of
groups 1 to 5, and the within subject factor ‘TIME’ (base-
line, days 1, 8, 15, 22, 29, 36, 43 and 50). Post-hoc t-tests
were only performed when ANOVAs showed a significant
GROUP X TIME interaction. Animals injected with saline
briefly incubated in lithium heparin were included in the
statistical analyses, yet their data are not displayed in the
figures, since these were mostly identical to those who were
injected with saline.
In order to test for significant group differences between
single blood injection and single saline injection, repeated
measures ANOVAs for all parameters were performed
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saline, that is, group 6 versus group 7) and the within sub-
ject factor ‘TIME’ (baseline, days 1, 8, 15, 22, 29, 36, 43
and 50). Again, whenever ANOVAs revealed a significant
GROUP X TIME interaction, post-hoc t-tests were calcu-
lated for descriptive analysis.
Group differences in histopathological scores obtained
from the tissues removed on day 50 were statistically evalu-
ated using Χ2 tests, since, here, no normal distribution couldFigure 1 Time course of pain-related behaviour in repeatedly injected
the ipsilateral knee joint were reduced in all blood or blood compartment
indicate the injections for all displayed data), while secondary hyperalgesia
between groups (B). The relative weight resting on the injected hindlimb w
or blood components (C). The guarding score indicating pain- and inflamm
groups, but most prominently in those animals receiving whole blood inje
in (E) to (H). For comparison, a naïve joint without injections is shown in (E
increasing signs of inflammatory changes in the joint space and in surroun
lower panel are magnifications of the indicated inset in the upper panel. A
blood cells. Scale bars are 500 μm. Data are presented as means ± SEM. Da
included in the statistical analysis are not displayed in the figure for clarity.
the mean; WB, whole blood.be established due to the categoric nature of the data.
Follow-up Mann–Whitney-tests were then used for descrip-
tive analysis. Statistical significance was assumed for P <0.05.
Results
Effects of repeated whole blood and blood compartment
injections on pain-related behaviour
When comparing pain-related behaviour during the obser-
vation period of 50 days, a significant main effect (GROUPanimals. Thresholds for primary mechanical hyperalgesia assessed at
injected animals compared to those injected with saline (A), arrows
obtained from the contralateral knee joint did not show differences
as slightly, yet non-significantly reduced in all groups receiving blood
ation-related gait disturbances was significantly increased in all
ctions (D). Knee joint histology from different time points is displayed
), while joints that received three, five or eight injections, displaying
ding tissues, are shown in (F), (G) and (H), respectively. Pictures in the
rrows indicate the (mild) inflammatory changes and intra-articular
ta of those animals receiving saline in lithium-heparin which were
* P <0.05; ** P <0.01; *** P <0.001. BL, baseline; SEM, standard error of
Figure 2 Inflammatory signs in repeatedly injected animals. In all parameters assessed, only those animals receiving multiple whole blood
injections showed significant signs of inflammation. Joint swelling was significantly increased in this group when compared to all other groups (A).
Arrows indicate the injections. Histopathological signs of chronic inflammation were likewise significantly increased in whole blood injected animals,
but not those receiving blood compartments (B), while signs for joint destruction only showed a trend (C). Numerically, C-reactive protein levels were
highest in whole blood injected animals, yet here, no statistical difference could be obtained between groups (D). Representative pictures of knee joint
histology from the different groups are displayed in (E) to (H). An animal that received eight saline injections is shown in (E). Here, no inflammatory
response is obvious. A specimen from a whole blood injected animal is displayed in (F), showing signs of synovitis and inflammation in the
surrounding tissues as well as blood cells in the joint space. Plasma-injected animals (G) and those that received cellular compartments are shown in
(H), revealing similar, yet milder pathology compared to whole blood. Pictures in the lower panel are magnifications of the indicated inset in the upper
panel. Arrows indicate the (mild) inflammatory changes and intra-articular blood cells. Scale bars are 500 μm. Data are presented as means ± SEM. Data
of those animals receiving saline in lithium-heparin which were included in the statistical analysis are not displayed in the figure for clarity.* P <0.05; **
P <0.01; *** P <0.001. BL, baseline; SEM, standard error of the mean; WB, whole blood.
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algesia as obtained from applying increasing pressure to the
blood-injected knee joint (F(32,105) = 1.736; P = 0.020).
Repeated saline injections led to a slight, but non-signifi-
cant decrease in pressure pain thresholds, while repeated
whole blood injections showed significantly decreased
thresholds from day 15 onwards. Both plasma and cellularcompartment injections showed a similar decrease in
thresholds up to day 15, but remained on a slightly higher
level until day 50 (see Figure 1A). Secondary hyperalgesia
as measured by mechanical pain thresholds at the contra-
lateral knee (PAM device) was not seen in any of the
groups (F(32,105) = 0.684; P = 0.890, Figure 1B). Likewise,
no secondary mechanical or thermal hyperalgesia could be
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aesthesiometer) or radiating heat (Hargreave’s method), re-
spectively, applied to the paws (secondary mechanical
hyperalgesia injected side F(32,105) = 1.095; P = 0.356 and
contralateral side F(32,105) = 1.028; P = 0.442; secondary
thermal hyperalgesia injected side F(32,105) = 0.699;
P = 0.876 and contralateral side F(32,105) = 1.045;
P = 0.419, data not shown).
Assessment of weight bearing showed a decrease from
50% body weight resting on the injected hind paw at base-
line to approximately 42% to 45% from day 15 onwards in
all blood or blood compartment injected groups (see
Figure 1C), yet statistical analysis did not reveal a significant
GROUP X TIME interaction (F(32,105) = 1.084; P = 0.370).
Gait analysis revealed significant differences between
groups for the parameter guarding score (F(32,105) =
2.159; P = 0.002). Here, most obvious disturbances of gait
were observed in those animals that received whole blood
injections and, to a lesser degree, in those animals receiving
either plasma or cellular components (Figure 1D). Interest-
ingly, these changes were the first to be observed, starting
on day 1 after the first injection, reaching a plateau from day
36 onwards for whole blood. Quantitative gait analysis, how-
ever, did not reveal significant differences between groups.
Here, outward rotation (angle between paws) was unaltered,
while stride length (distance from left to right paw print)
tended to decrease towards later observation time points,
but did not reach statistical significance (F(32,101) = 1.256;
P = 0.113 and F(32,101) = 1.183; P = 0.261, respectively,
Table 1, data for contralateral side not shown).
A similar time course as for the development of pain-
related behaviour could be observed for the histological
changes in the affected knee joints (Figure 1E-H). Here, in
naïve animals no alterations of the joint and no signs of
inflammation can be observed (Figure 1E). After three
whole blood injections (corresponding to day 15), there is
a slight inflammatory reaction of the lining cells, but noTable 1 Quantitative gait parameters (injected side)
Distance left to right paw (stride length) [cm]
Test day BL 1 8 15
Saline 5.4 ± 0.1 5.2 ± 0.3 4.9 ± 0.4 5.2 ± 0.2
WB 5.8 ± 0.2 5.8 ± 0.4 5.3 ± 0.3 5.0 ± 0.3
Plasma 5.6 ± 0.2 5.1 ± 0.3 5.3 ± 0.3 5.2 ± 0.3
Cells 5.9 ± 0.2 5.4 ± 0.3 5.4 ± 0.3 5.4 ± 0.1
Angle between paws (outward rotation) (°)
Test day BL 1 8 15
Saline 30 ± 2 31 ± 2 31 ± 4 31 ± 3
WB 32 ± 2 33 ± 3 32 ± 2 34 ± 2
Plasma 32 ± 2 31 ± 2 32 ± 2 31 ± 1
Cells 34 ± 2 37 ± 2 33 ± 2 35 ± 2
Data are presented as mean ± SEM. There were no significant differences betweengross pathology (Figure 1F). From the fifth whole blood
injection onwards (corresponding to days 29 and above),
blood cells remain visible in the joint space, and an inflam-
matory reaction of the synovia, but also of surrounding
tissues can be observed (Figure 1G,H).
Effects of repeated whole blood and blood compartment
injections on inflammation and joint destruction
Joint swelling showed significant differences between
groups over time (F(32,105) = 2.304; P <0.001). Here,
both plasma and cellular compartments showed slightly,
yet non-significantly, increased joint diameters as com-
pared to saline injections, while whole blood injections
led to significantly increased joint swelling from day 8
onwards, with approximately four-fold total levels as
compared to blood compartments at the end of the ob-
servation period (Figure 2A). Histological analysis of the
joints obtained on day 50 mirrored these findings, since
here, scores for chronic inflammatory changes were sig-
nificantly increased in whole blood injected animals
compared to saline, but not in those animals receiving
blood compartments (Χ2 = 12.558; P = 0.014, Figure 2B).
In tendency, the same pattern was observed for joint de-
struction (Χ2 = 13.456; P = 0.009, Figure 2C). Histo-
logical sections of representative animals from the
different groups (saline, whole blood, plasma and cells)
are displayed in Figure 2E-H.
The inflammatory marker C-reactive protein obtained
from venous blood on day 50 was slightly increased in
whole blood injected animals, yet one way ANOVA did not
reveal significant differences between groups (F = 1.321;
P = 0.285, Figure 2D).
Effects of a single whole blood injection on pain-related
behaviour, inflammation and joint destruction
A single intraarticular injection of whole blood was
compared to a single saline injection. Measures of primary22 29 36 43 50
4.9 ± 0.4 4.9 ± 0.3 5.2 ± 0.3 4.9 ± 0.3 5.5 ± 0.2
4.9 ± 0.2 5.0 ± 0.4 4.5 ± 0.3 5.1 ± 0.5 4.9 ± 0.3
5.1 ± 0.3 4.3 ± 0.3 4.5 ± 0.2 4.5 ± 0.3 4.4 ± 0.4
4.9 ± 0.3 4.8 ± 0.2 4.5 ± 0.4 5.0 ± 0.3 4.1 ± 0.3
22 29 36 43 50
28 ± 2 29 ± 2 31 ± 2 31 ± 2 30 ± 3
32 ± 2 32 ± 2 36 ± 2 34 ± 1 32 ± 1
32 ± 2 35 ± 2 34 ± 1 35 ± 3 33 ± 2
35 ± 2 32 ± 2 33 ± 2 36 ± 2 36 ± 2
groups. BL, baseline; SEM, standard error of the mean; WB, whole blood.
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(F(8,9) = 2.42; P = 0.105) were not different between
groups (Figure 3A,B). Likewise, there was no difference in
weight bearing (F(8,9 = 1.19; P = 0.397) (Figure 3C).
Despite a slight increase in the guarding score on day 1
which was not significantly different from saline, there
were no signs of gait disturbances (F(8,9) = 2.39; P =
0.113) (Figure 3D, quantitative analyses not shown). Like-
wise, there was no difference between groups regarding
joint swelling (F(8,9) = 3.07; P = 0.057) (Figure 3E) or histo-
logically assessed inflammation and joint destruction (not
shown). Thus, in summary, a single whole blood injection
did not cause persisting changes over time.Figure 3 Parameters of pain-related behaviour and
inflammation in animals injected with saline or whole blood
once on day 0 (arrow). No differences were obvious for primary
hyperalgesia (A), secondary hyperalgesia (B), weight bearing (C),
guarding score (D) or joint swelling (E). Data are presented as
means ± SEM. BL, baseline; SEM, standard error of the mean.Discussion
At present, no animal models of blood-induced arthrop-
athy have been specifically validated regarding haemo-
philic or blood-induced joint pain. We employed a
battery of tests to characterize pain-related behaviour in
a rat model of autologous intraarticular injections as ori-
ginally described by Niibayashi and coworkers [7].
While a single intraarticular injection of whole blood
led to very mild, non-significant and reversible pain-
related behaviour, repeated injections resulted in signifi-
cant and sustained primary hyperalgesia and an increase
in guarding, as well as a trend for weight bearing alter-
ations. This pain-related behaviour became obvious fol-
lowing the third injection. Secondary hyperalgesia and
quantitative gait parameters were not altered, even after
multiple injections. Injections of blood compartments led
to a similar, yet clearly milder pain phenotype. In whole
blood injected animals, a significant inflammatory re-
sponse could be observed also. Overall, this model may
serve to test novel treatment principles for haemophilic
arthropathy and related pain states. However, this may be
limited to different routes of administration and com-
pound classes. Since there is no genetic factor VIII defi-
ciency, supplementation regimes cannot be evaluated in
this model. Furthermore, topically injected compounds
should be considered with caution, since these may inter-
fere with the model itself. However, for any route of ad-
ministration other than intra-articular injection, the model
appears robust and viable.
Choice of the model
In haemophilia research, several animal models have been
described. These include genetic models in dogs (for ex-
ample, Chapel-Hill colony for haemophilia A, [17]) and
mice [18] or the injection of inhibitors or of antibodies
against clotting factors or their receptors [19-21]. In all of
these models, however, hardly any spontaneous bleedings
into joints are seen [22] and, therefore, they need to be in-
duced, for example, by blunt trauma [23]. For the examin-
ation of localized phenomena induced by bleedings,
injections of blood in dogs and rats have previously been
utilised [7,24]. For our purpose, we chose the latter since,
here, bleedings can be simulated in a standardized fashion
and variability between animals can thus be kept small
(time course, regular testing, blood volume). Furthermore,
joint alterations similar to haemophilic arthropathy have
been described [7] in this model. Finally, this study design
allowed us to examine the isolated effects of different
blood components. Certainly, this choice limits our study
with respect to factor VIII/IX content and related clotting
disorders which are not likewise simulated. Since in the
genetic models, however, traumatic impact is needed, re-
sults from such a setting are likewise biased. Despite more
data being available for the respective canine model, we
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tests are best validated.
Employing this model, we could establish primary
hyperalgesia starting from day 15, following the third
whole blood, plasma or cell injection. At the same time,
the first mild signs of synovitis become obvious which ag-
gravate with additional injections. From other studies it is
known that other signs of haemophilic arthropathy also
become evident only after repeated injections/bleedings
[25,26]. Moreover, while acute injury with haemarthrosis
in mice deficient for factor VIII immediately leads to a
transient loss of locomotor performance as assessed using
a rotarod, those animals that, in fact, develop synovitis
after three injuries show a delayed, but highly significant
alteration of their locomotor behaviour which may be
influenced by both pain and joint destruction [27].
Interestingly, we found a reduction of pressure pain
thresholds by 50% which mirrors those seen in people with
haemophilia [4], thereby matching the clinical situation. In
contrast to more aggressive models of rheumatoid arthritis
such as collagen-induced arthritis or antigen-induced arth-
ritis [15,28], however, we were not able to detect any
mechanical or thermal secondary hyperalgesia, that is, re-
duced pain thresholds in areas remote from the injected
joint. The observed joint pain and inflammation further
led to slight functional alterations, best depicted in the
guarding score which quantifies limping of the animals.
Quantitative gait parameters were not significantly af-
fected, despite a trend towards a reduction in stride length
in the late observation phase. This again translates well to
the clinical situation, where a discrete reduction of stride
length was also observed using elaborate methodology
[29]. The inflammatory changes observed in this study are
comparable to those described in the literature for re-
peated intraarticular blood injections in animal models
[22,30] as well as to the synovitis and joint destruction
seen in PWH [31].
Relative contribution of blood compartments
Several factors have been identified which contribute to
haemophilic arthropathy or blood-induced joint disease
[2,32]. To date, however, it is not entirely clear which
blood components drive blood-induced joint disease in
different stages. There is convincing evidence that in-
creased iron concentrations following erythrocyte degrad-
ation play a significant role. Here, heme, hemosiderin and/
or heme-derived iron are considered toxic, since they can
mediate oxidative stress and inflammation [32-34]. In
addition, white blood cells, particularly mononuclear cells,
have been implicated in haemophilic arthropathy. They
can enter the joint either by the bleeding itself or second-
arily due to chemotaxis, following an initial inflammatory
response of the cartilage tissue [32]. Upon activation by
synovial triggering, these cells then release, besides othercytokines and inflammatory mediators, IL-1β and TNF-α
which can then maintain and exacerbate the inflammatory
response, similar to other arthritic conditions [35]. Finally,
blood plasma components have also been shown to add to
the pathophysiology. For instance, thrombin and fibrin
have been shown to potentially exacerbate inflammatory
responses in haemophilic joint conditions [36,37]. A differ-
ent explanation for long-term arthropathy in haemophilia,
following multiple bleedings, may be a secondary develop-
ment of auto-immune joint disease. Recently, Murakami
and coworkers could show that repeated microbleedings
could facilitate autoimmune arthritis in an animal model,
thereby aggravating inflammation [38].
Despite this knowledge of the overall pathophysiology
of blood-induced joint damage, little is known about the
relative contribution of these components to the gener-
ation of joint pain. Of the mechanisms described, most
data exist for the role of pro-inflammatory cytokines in
joint pain [39]. In this study, we thus aimed at differenti-
ating those effects caused by whole blood or isolated
plasma or cellular components. Here, the injection of
whole blood caused the most severe pain phenotype,
and also the strongest inflammation, thereby suggesting
a role for cytokine-induced peripheral sensitization of
nociceptors. Furthermore, our data show an additive ef-
fect of both cells and plasma on pain-related behaviour
and inflammation, with whole blood injections revealing
the strongest effects. This is somewhat in contrast to
in vitro studies investigating inhibition of proteoglycan
synthesis which showed nearly maximal effects when
erythrocytes and mononuclear cells were incubated with
chondrocytes, whereas addition of plasma did not cause
further aggravation [40,41]. It is not clear, however, to
what extent proteoglycan synthesis and nociception in
the knee joint may be linked.
Single whole blood injection
In order to differentiate multiple intraarticular bleedings
reflecting a model for haemophilic arthropathy from trau-
matic joint bleeding, as clinically mostly observed in anter-
ior cruciate tears [42], we also examined one group
receiving a single injection. Here, despite a small, non-
significant increase in guarding early after the injection,
no gross abnormalities could be observed. This is well in
line with data from a canine study, in which dogs showed
nearly normal weight bearing already one hour after
intraarticular joint injection [24]. The discrepancy between
a usually painful haemarthrosis in patients and the absence
of pain-related behaviour in this model can be explained by
the blood volume in the knee joint. After trauma, blood
usually fills the entire joint cavity, while here, the volume
was restricted. The main question to be answered in this
study was whether a single (comparable) injection of whole
blood would induce long-term changes, as might be
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and from in vitro studies [40,43]. This is clearly not the case
and is, therefore, in line with previous in vivo studies which
suggested long-term bleeding-related joint damage only oc-
curs when the trauma also destabilizes the knee joint, for
example, by ligament rupture [24,44].
Limitations
In addition to considerations regarding the choice of the
model (see above), one additional potential limitation
needs to be addressed: for the examination of blood com-
partments, we chose always to inject the same volume and
aimed at maintaining the same relative content of cells/
plasma as in whole blood. This means that the cells were
re-suspended in saline and that the plasma was diluted in
saline prior to injection. This may have artificially reduced
the efficacy of the two compartments and, thus, may ex-
plain differing findings from a canine study, in which the
cellular components alone were shown to exhibit the same
effects as whole blood [45]. In this particular study, how-
ever, cells were concentrated up to the injection volume.
In contrast, our approach was to inject the same total con-
tent of cells/plasma into the joint.
Conclusions
In this study, we validated the rat model of repeated au-
tologous intraarticular injections of blood as a model for
joint pain in PWH. In particular, the time course, the need
for repeated injections/bleedings, the concomitant inflam-
matory response and, finally, the relative reduction in
pressure pain thresholds are comparable to those signs
and symptoms observed in PWH. Mechanistically, blood
cells and plasma need to be present in the joint to induce
the full picture of haemophilic arthropathy, displaying
mostly additive effects. Therefore, this model may be
utilised in the future for testing novel antinociceptive prin-
ciples in haemophilia-associated joint pain.
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